Safety, Tolerability, Pharmacokinetics, and Efficacy of Terlipressin Delivered by Continuous Intravenous Infusion in Patients with Cirrhosis and Refractory Ascites

Figure 3

Simulated plasma concentrations of terlipressin with IV bolus 1 mg every 6 hours [14] vs. IV continuous infusion of 2, 3, or 4 mg/d in current study.